Manning & Napier Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$136M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$132M |
| 3 |
DaVita
DVA
|
+$113M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$82.4M |
| 5 |
Qorvo
QRVO
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$112M |
| 2 |
Salesforce
CRM
|
+$97.7M |
| 3 |
Liberty Global Class A
LBTYA
|
+$85.7M |
| 4 |
America Movil
AMX
|
+$79.5M |
| 5 |
Ambev
ABEV
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.24% |
| 2 | Technology | 11.76% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.92% |
Similar funds
Manning & Napier Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, Manning & Napier Advisors held 332 positions worth $11.7B, up 0.35% from $11.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Manning & Napier Advisors withdrew a net $475M in Q3 2017, closing 12 positions and reducing 204 holdings. Its most notable exit was Liberty Global Class A, an estimated $85.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Manning & Napier Advisors opened a new position in Incyte worth $125M.
- Manning & Napier Advisors's largest Q3 2017 buy was Incyte: 1,071,325 shares worth $125M.
- Manning & Napier Advisors added most to DaVita in Q3 2017, an estimated $113M increase.
- Manning & Napier Advisors's biggest Q3 2017 reduction was Vertex Pharmaceuticals, cutting an estimated $112M.
- Manning & Napier Advisors fully exited Liberty Global Class A in Q3 2017, selling an estimated $85.7M.
- Manning & Napier Advisors's ten largest holdings make up 29% of its $11.7B portfolio in Q3 2017.
- Manning & Napier Advisors opened 20 new positions and closed 12 in Q3 2017.
- Manning & Napier Advisors's portfolio value rose 0.35% quarter-over-quarter to $11.7B.
Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.